Wang L, Zhang J, Liu F, Shi Q, Gao F, Li J
J Transl Med. 2024; 22(1):1049.
PMID: 39574146
PMC: 11580642.
DOI: 10.1186/s12967-024-05879-0.
Campisi M, Cannella L, Bordin A, Moretto A, Scapellato M, Mason P
Int J Mol Sci. 2024; 25(15).
PMID: 39125624
PMC: 11311509.
DOI: 10.3390/ijms25158056.
Dasgupta S, Das S, Chakraborty D
J Family Med Prim Care. 2024; 13(7):2683-2691.
PMID: 39071025
PMC: 11272021.
DOI: 10.4103/jfmpc.jfmpc_1862_23.
Kraft B, Verhulst S, Lai T, Sullenger B, Wang Y, Rountree W
Front Immunol. 2024; 15:1356638.
PMID: 38550590
PMC: 10972845.
DOI: 10.3389/fimmu.2024.1356638.
Grand R
J Gen Virol. 2023; 104(11).
PMID: 37948194
PMC: 10768691.
DOI: 10.1099/jgv.0.001918.
The Diagnostic, Prognostic, and Therapeutic Potential of Cell-Free DNA with a Special Focus on COVID-19 and Other Viral Infections.
Hovhannisyan G, Harutyunyan T, Aroutiounian R, Liehr T
Int J Mol Sci. 2023; 24(18).
PMID: 37762464
PMC: 10532175.
DOI: 10.3390/ijms241814163.
Association between leukocyte telomere length and COVID-19 severity.
Mahmoodpoor A, Sanaie S, Eskandari M, Behrouzi N, Taghizadeh M, Roudbari F
Egypt J Med Hum Genet. 2023; 24(1):37.
PMID: 37273887
PMC: 10225776.
DOI: 10.1186/s43042-023-00415-z.
Is COVID-19 severity associated with telomere length? A systematic review and meta-analysis.
Haridoss M, Ayyasamy L, Bagepally B
Virus Genes. 2023; 59(4):489-498.
PMID: 37261700
PMC: 10234232.
DOI: 10.1007/s11262-023-02010-1.
Parameters and Morphological Changes of Erythrocytes and Platelets of COVID-19 Subjects: A Longitudinal Cohort Study.
Shen L, Chen L, Chi H, Luo L, Ruan J, Zhao X
Infect Drug Resist. 2023; 16:1657-1668.
PMID: 36992967
PMC: 10041993.
DOI: 10.2147/IDR.S400735.
Enzymatic approaches against SARS-CoV-2 infection with an emphasis on the telomere-associated enzymes.
Valdiani A, Ofoghi H
Biotechnol Lett. 2023; 45(3):333-345.
PMID: 36707451
PMC: 9883136.
DOI: 10.1007/s10529-023-03352-4.
Accelerated ageing is associated with increased COVID-19 severity and differences across ethnic groups may exist.
Reeves J, Kooner J, Zhang W
Front Public Health. 2022; 10:1034227.
PMID: 36582365
PMC: 9792858.
DOI: 10.3389/fpubh.2022.1034227.
extract as an immunity modulator against cancer via telomerase inhibition.
Valdiani A, Ofoghi H, Akbarizare M, Talei D
3 Biotech. 2022; 12(11):319.
PMID: 36245958
PMC: 9549450.
DOI: 10.1007/s13205-022-03373-2.
TRF2 inhibition rather than telomerase disruption drives CD4T cell dysfunction during chronic viral infection.
Nguyen L, Nguyen L, Zhao J, Schank M, Dang X, Cao D
J Cell Sci. 2022; 135(13.
PMID: 35660868
PMC: 9377711.
DOI: 10.1242/jcs.259481.
Management of Hematologic Malignancies in the Era of COVID-19 Pandemic: Pathogenetic Mechanisms, Impact of Obesity, Perspectives, and Challenges.
Tsilingiris D, Nasiri-Ansari N, Spyrou N, Magkos F, Dalamaga M
Cancers (Basel). 2022; 14(10).
PMID: 35626099
PMC: 9139192.
DOI: 10.3390/cancers14102494.
Are Dyskeratosis Congenita patients at higher risk of symptomatic COVID-19?.
Dorgaleleh S, Naghipoor K, Hozhabrpour A, Vahidnezhad H
Med Hypotheses. 2022; 163:110843.
PMID: 35464998
PMC: 9011900.
DOI: 10.1016/j.mehy.2022.110843.
Telomeres and Mitochondrial Metabolism: Implications for Cellular Senescence and Age-related Diseases.
Gao X, Yu X, Zhang C, Wang Y, Sun Y, Sun H
Stem Cell Rev Rep. 2022; 18(7):2315-2327.
PMID: 35460064
PMC: 9033418.
DOI: 10.1007/s12015-022-10370-8.
Circulating biomarkers of inflammaging as potential predictors of COVID-19 severe outcomes.
Sabbatinelli J, Matacchione G, Giuliani A, Ramini D, Rippo M, Procopio A
Mech Ageing Dev. 2022; 204:111667.
PMID: 35341896
PMC: 8949647.
DOI: 10.1016/j.mad.2022.111667.
Telomere dysfunction in ageing and age-related diseases.
Rossiello F, Jurk D, Passos J, dAdda di Fagagna F
Nat Cell Biol. 2022; 24(2):135-147.
PMID: 35165420
PMC: 8985209.
DOI: 10.1038/s41556-022-00842-x.
Inflammatory cytokine storms severity may be fueled by interactions of micronuclei and RNA viruses such as COVID-19 virus SARS-CoV-2. A hypothesis.
Kirsch-Volders M, Fenech M
Mutat Res Rev Mutat Res. 2021; 788:108395.
PMID: 34893160
PMC: 8479308.
DOI: 10.1016/j.mrrev.2021.108395.
DNA damage response at telomeres boosts the transcription of SARS-CoV-2 receptor ACE2 during aging.
Sepe S, Rossiello F, Cancila V, Iannelli F, Matti V, Cicio G
EMBO Rep. 2021; 23(2):e53658.
PMID: 34854526
PMC: 8811650.
DOI: 10.15252/embr.202153658.